Frank Ortega v. Natural Balance Inc

CourtDistrict Court, C.D. California
DecidedApril 7, 2021
Docket2:13-cv-05942
StatusUnknown

This text of Frank Ortega v. Natural Balance Inc (Frank Ortega v. Natural Balance Inc) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Frank Ortega v. Natural Balance Inc, (C.D. Cal. 2021).

Opinion

JS-6 1

2 3

6 UNITED STATES DISTRICT COURT 7

8 CENTRAL DISTRICT OF CALIFORNIA 9 Case No. 2:13-cv-05942-AB-Ex 10 IN RE COBRA SEXUAL ENERGY 11 SALES PRACTICES LITIGATION FINAL ORDER AND JUDGMENT (1) GRANTING FINAL APPROVAL OF CLASS 12 ACTION SETTLEMENT; 13 (2) AWARDING CLASS COUNSEL FEES AND 14 EXPENSES; (3) AWARDING CLASS REPRESENTATIVE 15 INCENTIVE AWARD; AND 16 (4) DISMISSING ACTION WITH PREJUDICE

17 Judge: The Honorable André Birotte, Jr. 18 Date: April 2, 2021 Time: 10:00 a.m. 19 Location: Courtroom 7B 20 21 22 23 24 25 26 27 28 1 Plaintiff Troy Lambert, individually and on behalf of the Class defined below, moves 2 for final approval of the class action settlement negotiated with the defendant in this action. 3 Now, having considered the record and the requirements of law, the motion is GRANTED 4 as set forth below. The settlement is FINALLY APPROVED. 5 The Court further finds and orders as follows: 6 Procedural History 7 A. The Allegations in the Complaint 8 Plaintiff filed his Complaint on August 14, 2013. Dkt. 1. Plaintiff’s central allegation 9 in this case is that Cobra was falsely and unlawfully marketed as an aphrodisiac drug. He 10 argued it violated both the general statute requiring approval of new drugs, as well as 21 11 C.F.R. § 310.528, a regulation dealing specifically with “herbal aphrodisiac” products. 12 Because the FDCA does not provide private plaintiffs standing to enforce drug laws, 13 Plaintiff brought his claims under the laws of California. 14 Plaintiff amended his Complaint on October 25, 2013. Dkt. 24. On November 8, 15 2013, Nutraceutical moved to dismiss the First Amended Complaint. Dkt. 35. Plaintiff 16 opposed on November 18, Dkt. 42, and Nutraceutical submitted its reply brief on 17 November 25. Dkt. 47. On December 16, the Court granted the motion in part, dismissing 18 the claims “of class members who are not California residents.” Dkt. 54 at 6. Plaintiff filed 19 his Second Amended Complaint on December 23, 2013. Dkt. 56. Nutraceutical Answered 20 the SAC on January 15, 2014. Dkt. 63. 21 B. Discovery 22 The Parties completed substantial discovery prior to negotiating the Settlement. On 23 November 25, 2013 Plaintiff served his First Sets of Requests for Production, 24 Interrogatories, and Requests for Admission on Nutraceutical. Nutraceutical served 25 responses to these requests on December 30, 2013 and supplemented its Interrogatory 26 Responses on January 14, 2014. Weston Decl. ¶ 2-3. 27 Plaintiff served his Second Sets of Requests for Production and Interrogatories on 1 and supplemented its RFP responses on May 23, 2014. Weston Decl. ¶ 5. 2 On June 4, 2014, Plaintiff served his Third Set of Requests for Production, to which 3 Nutraceutical responded on July 7, 2014. Plaintiff served a Fourth Set of Requests for 4 Production and a Second Set of Interrogatories on July 23, 2020. Weston Decl. ¶¶ 6-7. 5 Additionally, on April 10 and 11, 2014, Plaintiff took the depositions of Jeffrey 6 Hinrichs, Nutraceutical’s Chief Operating Officer and Executive Vice President, and 7 Christopher Neuburger, Nutraceutical’s VP of Marking and Sales. Weston Decl. ¶ 8. 8 Nutraceutical also took substantial discovery prior to negotiating the Settlement. On 9 December 20, 2013, Nutraceutical served its First Sets of Interrogatories and Requests for 10 Production on Lambert. Weston Decl. ¶ 9. Nutraceutical served a Second Set of 11 Interrogatories on Lambert on January 15, 2014. Weston Decl. ¶ 10. On July 9, 2014, 12 Nutraceutical served its First Set of Requests for Admission, as well as its Second Set of 13 Requests for Production and Third Set of Interrogatories. Lambert responded to all of this 14 discovery, and Nutraceutical took Lambert’s deposition on April 4, 2014. Weston Decl. ¶¶ 15 10-12. Thus, the Parties, having taken substantial discovery, were well-informed in 16 negotiating the Settlement. 17 C. Motion Practice Before This Court and On Appeal. 18 Prior to negotiating the Settlement, the Parties also engaged in extensive motion 19 practice relating to both class certification and the merits. Further, the Parties briefed 20 certification issues before both the Ninth Circuit and Supreme Court. 21 Following the motion to dismiss briefing and orders described supra, on April 7, 22 2014, Plaintiff moved for class certification, which was granted on June 19, 2014. Dkts. 23 65, 80. 24 On November 24, 2014, the Parties both submitted summary judgment motions. 25 Dkts. 125, 129. They submitted their opposition briefs on December 29, Dkts. 148-149. 26 Nutraceutical submitted its reply brief on January 19, 2015. Dkt. 159. Plaintiff filed his 27 reply brief on January 26. Dkt. 161. The Court continued the hearing on the dueling MSJs 1 Nutraceutical moved to decertify the class on November 17, 2014. Dkt. 111. Plaintiff 2 opposed on December 1, 2014, Dkt. 141, and Nutraceutical submitted its reply brief on 3 December 8, 2014. Dkt. 144. The Court granted the motion to decertify on February 20, 4 2015. Dkt. 175. 5 During a March 2, 2015 Status Conference, Plaintiff informed the Court of his 6 intention to file a Motion for Reconsideration of the Decertification Order, and the Court 7 set a briefing schedule for the motion. Dkt. 177. Plaintiff filed his Motion for 8 Reconsideration on March 12, 2015. Dkt. 183. Nutraceutical opposed on March 30, Dkt. 9 189, and Plaintiff filed his reply brief on April 13. Dkt. 192. On June 24, the Court denied 10 Plaintiff’s Motion for Reconsideration. Dkt. 195. Plaintiff filed a petition for permission to 11 appeal the order pursuant to Fed. R. Civ. P. 23(f), Dkt. 203, which was granted. Dkt. 209. 12 The Motions Panel’s order accepting the petition was without prejudice to reargument of 13 Defendant’s position that the petition was untimely a second time before the Merits Panel. 14 On September 15, 2017, the Ninth Circuit reversed the decertification order. 15 Lambert v. Nutraceutical Corp., 870 F.3d 1170, 1184 (9th Cir. 2017). Nutraceutical filed 16 a petition for a writ of certiorari with the Supreme Court on February 1, 2018. On June 25, 17 2018, the Supreme Court granted the petition. Nutraceutical Corp. v. Lambert, 138 S. Ct. 18 2675 (2018). The Supreme Court issued an opinion reversing the Ninth Circuit’s order 19 because the initial petition was untimely, and remanding the action for further proceedings 20 on February 26, 2019. Nutraceutical Corp. v. Lambert, 139 S. Ct. 710 (2019). 21 On April 9, 2019, on remand from the Supreme Court to the Ninth Circuit, Lambert 22 filed a Motion for Additional Briefing, which was granted on April 16, 2019. Lambert filed 23 his supplemental brief on May 4, 2019, and Nutraceutical submitted its supplemental brief 24 on June 13, 2019. The Ninth Circuit issued an order dismissing Lambert’s appeal on 25 August 27, 2019 and remanded the action for further proceedings. Lambert v. Nutraceutical 26 Corp., 783 F. App'x 720 (9th Cir. 2019). 27 On October 4, 2019, the Court held a status conference and set a schedule for 1 | supplemental briefs, Dkts. 255, 259, 260, and on January 28, 2020, the Court entered an 2 || order rescinding it prior decertification order and reinstating class certification. Lambert v. 3 || Nutraceutical Corp., 2020 U.S. Dist. LEXIS 6391, at *33 (C.D. Cal. Jan. 8, 2020). 4 Nutraceutical filed a Rule 23(f) Petition to appeal the Court’s January 8, 2020 Order, 5 ||and the Court entered an order staying the action during the pendency of the Petition on 6 || January 27, 2020. Dkt. 270. The Ninth Circuit denied the Petition on July 16, 2020 with 7 || Judge Christen dissenting from the denial. Lambert v. Nutraceutical Corp., 2020 U.S. App. 8 || LEXIS 22230 (9th Cir. July 16, 2020).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Ratnasingam v. Holder
556 F.3d 10 (First Circuit, 2009)
In Re Bluetooth Headset Products Liability
654 F.3d 935 (Ninth Circuit, 2011)
Harry Dennis v. Stephanie Berg
697 F.3d 858 (Ninth Circuit, 2012)
Serrano v. Stefan Merli Plastering Co., Inc.
262 P.3d 568 (California Supreme Court, 2011)
Moreno v. City of Sacramento
534 F.3d 1106 (Ninth Circuit, 2008)
Post Bros. Construction Co. v. Yoder
569 P.2d 133 (California Supreme Court, 1977)
Syncor Erisa Litigation v. Cardinal Health, Inc.
516 F.3d 1095 (Ninth Circuit, 2008)
Rodriguez v. West Publishing Corp.
563 F.3d 948 (Ninth Circuit, 2009)
In Re Equity Funding Corp. of America Securities Litigation
438 F. Supp. 1303 (C.D. California, 1977)
In Re Omnivision Technologies, Inc.
559 F. Supp. 2d 1036 (N.D. California, 2008)
Parkinson v. Hyundai Motor America
796 F. Supp. 2d 1160 (C.D. California, 2010)
Science Applications International Corp. v. Superior Court
39 Cal. App. 4th 1095 (California Court of Appeal, 1995)
Dupler v. Costco Wholesale Corp.
705 F. Supp. 2d 231 (E.D. New York, 2010)
Lindelli v. Town of San Anselmo
43 Cal. Rptr. 3d 707 (California Court of Appeal, 2006)
Brennan v. Bally Total Fitness
198 F. Supp. 2d 377 (S.D. New York, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
Frank Ortega v. Natural Balance Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/frank-ortega-v-natural-balance-inc-cacd-2021.